Clinical Trial

Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 28, 2025 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective is to evaluate the safety and efficacy of a topical serum (AGE serum) in improving visible signs of aging (e.g., fine lines, wrinkles, sagging, texture, radiance) on the full face and neck.The study will be conducted in non-menopausal female and male subjects who are on glucagon-like peptide-1 (GLP-1) agonist therapy for weight loss.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-10.
Trial Details
NCT Number NCT07216352
Lead Sponsor Goldman, Butterwick, Fitzpatrick and Groff
Collaborators: L'Oreal
Conditions Laxity; Skin
Enrollment 25 participants
Start Date 2025-10-25
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-28